Your browser doesn't support javascript.
loading
Evolution of antithrombotic therapy in patients undergoing percutaneous coronary intervention: a 40-year journey.
Cao, Davide; Chandiramani, Rishi; Chiarito, Mauro; Claessen, Bimmer E; Mehran, Roxana.
Affiliation
  • Cao D; Center for Interventional Cardiovascular Research and Clinical Trials, The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1030, New York, NY 10029-6574, USA.
  • Chandiramani R; Center for Interventional Cardiovascular Research and Clinical Trials, The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1030, New York, NY 10029-6574, USA.
  • Chiarito M; Center for Interventional Cardiovascular Research and Clinical Trials, The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1030, New York, NY 10029-6574, USA.
  • Claessen BE; Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20090 Pieve Emanuele, Milan, Italy.
  • Mehran R; Cardio Center, Humanitas Clinical and Research Hospital IRCCS, Via Alessandro Manzoni 56, 20090 Rozzano, Milan, Italy.
Eur Heart J ; 42(4): 339-351, 2021 01 21.
Article in En | MEDLINE | ID: mdl-33367641

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Atrial Fibrillation / Coronary Artery Disease / Percutaneous Coronary Intervention Limits: Humans Language: En Journal: Eur Heart J Year: 2021 Type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Atrial Fibrillation / Coronary Artery Disease / Percutaneous Coronary Intervention Limits: Humans Language: En Journal: Eur Heart J Year: 2021 Type: Article Affiliation country: United States